The FDA approves Apotex Corp.'s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could ...

Semaglutide 25 mg tablets were tied to significantly greater mean weight loss vs. orforglipron 36 mg tablets, according to ...

Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...

Semaglutide use was not tied to a higher risk for non-arteritic anterior ischemic optic neuropathy, or NAION, in patients ...

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

Generic semaglutide surge dents Mounjaro sales, reshaping India's fast-growing GLP-1 diabetes and obesity drug market ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

More than a million patients who have had a heart attack or stroke and are overweight will now be eligible for weight loss ...

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of ...

In the Phase 3 ACHIEVE-3 trial, oral orforglipron demonstrated superior HbA1c and weight reduction vs oral semaglutide in patients with T2D.

Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price ...